A more recent study by Jin et al. reported enhanced IFNβ expression in head and neck cancer cells and melanoma tumors implanted in mice, post-treatment with RT (1 fraction of 8 Gy) and an ataxia-telangiectasia mutated inhibitor [23]. Here, IFNB1 is linked to head and neck cancer.